Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
- PMID: 35602506
- PMCID: PMC9120524
- DOI: 10.3389/fmed.2022.865034
Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
Abstract
Alport syndrome is inherited as an X-linked (XL), autosomal recessive (AR), or autosomal dominant (AD) disease, where pathogenic COL4A3 - COL4A5 variants affect the basement membrane collagen IV α3α4α5 network. About 50% of pathogenic variants in each gene (major rearrangements and large deletions in 15%, truncating variants in 20%, splicing changes in 15%) are associated with "severe" disease with earlier onset kidney failure, and hearing loss and ocular abnormalities in males with XL inheritance and in males and females with AR disease. Severe variants are also associated with early proteinuria which is itself a risk factor for kidney failure. The other half of pathogenic variants are missense changes which are mainly Gly substitutions. These are generally associated with later onset kidney failure, hearing loss, and less often with major ocular abnormalities. Further determinants of severity for missense variants for XL disease in males, and in AD disease, include Gly versus non-Gly substitutions; increased distance from a non-collagenous interruption or terminus; and Gly substitutions with a more (Arg, Glu, Asp, Val, and Trp) or less disruptive (Ala, Ser, and Cys) residue. Understanding genotype-phenotype correlations in Alport syndrome is important because they help predict the likely age at kidney failure, and the need for early and aggressive management with renin-angiotensin system blockade and other therapies. Genotype-phenotype correlations also help standardize patients with Alport syndrome undergoing trials of clinical treatment. It is unclear whether severe variants predispose more often to kidney cysts or coincidental IgA glomerulonephritis which are recognized increasingly in COL4A3-, COL4A4 - and COL4A5-associated disease.
Keywords: AD Alport syndrome; AR Alport syndrome; Alport syndrome; COL4A3; COL4A4; COL4A5; XL Alport syndrome; genotype-phenotype correlation.
Copyright © 2022 Savige, Huang, Croos Dabrera, Shukla and Gibson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.Sci Rep. 2022 Feb 17;12(1):2722. doi: 10.1038/s41598-022-06525-9. Sci Rep. 2022. PMID: 35177655 Free PMC article.
-
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.PLoS One. 2016 Sep 14;11(9):e0161802. doi: 10.1371/journal.pone.0161802. eCollection 2016. PLoS One. 2016. PMID: 27627812 Free PMC article.
-
Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities.Kidney Int Rep. 2022 Jun 7;7(9):1933-1938. doi: 10.1016/j.ekir.2022.06.001. eCollection 2022 Sep. Kidney Int Rep. 2022. PMID: 36090501 Free PMC article. Review.
-
Digenic Alport Syndrome.Clin J Am Soc Nephrol. 2022 Nov;17(11):1697-1706. doi: 10.2215/CJN.03120322. Epub 2022 Jun 8. Clin J Am Soc Nephrol. 2022. PMID: 35675912 Free PMC article. Review.
-
Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome.Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35419377 Free PMC article.
Cited by
-
Identification of novel COL4A5 variants and prenatal diagnosis in three large families.Sci Rep. 2025 Mar 8;15(1):8135. doi: 10.1038/s41598-025-92649-7. Sci Rep. 2025. PMID: 40057613 Free PMC article.
-
GWAS for the composite traits of hematuria and albuminuria.Sci Rep. 2023 Oct 23;13(1):18084. doi: 10.1038/s41598-023-45102-6. Sci Rep. 2023. PMID: 37872228 Free PMC article.
-
Alport syndrome and Alport kidney diseases - elucidating the disease spectrum.Curr Opin Nephrol Hypertens. 2024 May 1;33(3):283-290. doi: 10.1097/MNH.0000000000000983. Epub 2024 Mar 13. Curr Opin Nephrol Hypertens. 2024. PMID: 38477333 Free PMC article. Review.
-
Molecular Review of Suspected Alport Syndrome Patients-A Single-Centre Experience.Genes (Basel). 2025 Feb 4;16(2):196. doi: 10.3390/genes16020196. Genes (Basel). 2025. PMID: 40004525 Free PMC article.
-
Hidden genetics behind glomerular scars: an opportunity to understand the heterogeneity of focal segmental glomerulosclerosis?Pediatr Nephrol. 2024 Jun;39(6):1685-1707. doi: 10.1007/s00467-023-06046-1. Epub 2023 Sep 20. Pediatr Nephrol. 2024. PMID: 37728640 Free PMC article. Review.
References
-
- Grunfeld JP, Joly D. Hereditary kidney diseases in adults. Rev Prat. (1997) 47:1566–9. - PubMed
-
- Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, et al. . Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. (2018) 93:1045–51. 10.1016/j.kint.2017.12.018 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous